Genomictree Inc.
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
228760 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 테크노10로 44-6, 대전광역시
- Website:
- https://genomictree.com/eng/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Genomictree Inc. is a biomarker-based molecular diagnostics company focused on developing and commercializing products for the early detection of cancer. The company specializes in identifying and utilizing DNA methylation biomarkers through its proprietary genomic-scale discovery tools. Its flagship product line, EarlyTect®, includes tests for the early screening of colorectal, lung, and bladder cancers. Genomictree also offers AccuraTect™ for companion diagnostics. The company's mission is to improve patient quality of life and reduce overall medical costs by providing innovative and accurate molecular diagnostic solutions to address unmet needs in the healthcare industry.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Genomictree Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all Genomictree Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Genomictree Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
